USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
PDS BIOTECHNOLOGY CORPORATION
Address:
500 Industrial Drive
Lawrenceburg, IN 47025-2971
Phone:
N/A
URL:
N/A
EIN:
120403151
DUNS:
783437804
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
Yes
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $315,779.00 2
STTR Phase I $174,273.00 1

Award List:

SBIR TOPIC 241 LIPID NANO-PARTICLE THERAPEUTIC CERVICAL CANCER VACCINE

Award Year / Program / Phase:
2007 / SBIR / Phase I
Award Amount:
$149,291.00
Agency:
HHS
Principal Investigator:
Bedu Frank
Abstract:
N/a

Nanoparticle peptide-based therapy for melanoma

Award Year / Program / Phase:
2008 / SBIR / Phase I
Award Amount:
$166,488.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Melanoma is currently the most deadly form of skin cancer. Current treatments include surgery, chemotherapy and immunotherapy. The five year survival rate for patients with metastatic melanoma is less than 10%. The obje ctive of the proposal is to develop a safe… More

Nanocrystal Delivery of Hydrophobic Anticancer Drugs

Award Year / Program / Phase:
2010 / STTR / Phase I
Award Amount:
$174,273.00
Agency:
HHS
Principal Investigator:
Frank Bedu-addo – 513-755-3065
Research Institution:
University Of North Carolina Chapel Hill
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): Nanosystems have been extensively investigated for drug delivery; however, there is a challenge in transferring nanotechnology from research laboratories into pharmaceutical industry. The scientific basis for this proposal originated from our three-phase… More